Overview
- Cigna unveiled the Lead to One strategic framework and committed a $3 billion, multi-year capital program focused on AI and productivity improvements while keeping its 2026 revenue and adjusted EPS guidance unchanged.
- The company set 2026–2030 targets that include 10–14% compound annual growth in adjusted EPS and roughly $50 billion in cumulative operating cash flow over the five years.
- Management said the AI spend will modernize internal systems, give staff AI-enabled analytics and improve supplier and vendor oversight to boost operational efficiency.
- Executives warned of ongoing pressure in Evernorth’s pharmacy benefit services and higher medical-cost trends, and shares fell about 3% during the Investor Day presentation.
- Cigna also announced a $10.5 million, three-year foundation program for people with complex needs, and investors should watch whether productivity gains and PBM fixes deliver the near-term financial improvements the company projects.